Sam-A Pharm. Co. Ltd
Sam-A Pharm. Co., Ltd operates as a pharmaceutical company in South Korea. The company offers a range of pharmaceutical products in the areas of respiratory, anti-biotics, anti-virals, anti-histamines, anti-fungals, dermatology, pain/inflammation, gastrointestinal, cardiovascular, metabolism, urological, and steroids, as well as psychotropic agents; and OTC products in the areas of respiratory, a… Read more
Sam-A Pharm. Co. Ltd (009300) - Total Liabilities
Latest total liabilities as of September 2025: ₩21.72 Billion KRW
Based on the latest financial reports, Sam-A Pharm. Co. Ltd (009300) has total liabilities worth ₩21.72 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Sam-A Pharm. Co. Ltd - Total Liabilities Trend (2009–2024)
This chart illustrates how Sam-A Pharm. Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Sam-A Pharm. Co. Ltd Competitors by Total Liabilities
The table below lists competitors of Sam-A Pharm. Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Arizona Lithium Limited
PINK:AZLAF
|
USA | $4.03 Million |
|
Jericho Oil Corp
PINK:JROOF
|
USA | $5.25 Million |
|
Neonode Inc
NASDAQ:NEON
|
USA | $6.02 Million |
|
W S Industries (I) Limited
NSE:WSI
|
India | ₹-1.98 Billion |
|
AJ Advance Technology Public Company Limited
BK:AJA
|
Thailand | ฿100.46 Million |
|
National Plastic Co Ltd Preferred
KO:004255
|
Korea | ₩168.34 Billion |
|
Shinih Enterprise Co Ltd
TW:9944
|
Taiwan | NT$2.35 Billion |
|
Air T Inc
NASDAQ:AIRT
|
USA | $375.87 Million |
Liability Composition Analysis (2009–2024)
This chart breaks down Sam-A Pharm. Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 7.79 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.10 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.09 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sam-A Pharm. Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sam-A Pharm. Co. Ltd (2009–2024)
The table below shows the annual total liabilities of Sam-A Pharm. Co. Ltd from 2009 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩28.76 Billion | -6.74% |
| 2023-12-31 | ₩30.84 Billion | +36.57% |
| 2022-12-31 | ₩22.58 Billion | +31.68% |
| 2021-12-31 | ₩17.15 Billion | +8.39% |
| 2020-12-31 | ₩15.82 Billion | -30.10% |
| 2019-12-31 | ₩22.63 Billion | +77.05% |
| 2018-12-31 | ₩12.78 Billion | +7.76% |
| 2017-12-31 | ₩11.86 Billion | -11.19% |
| 2016-12-31 | ₩13.36 Billion | +4.11% |
| 2015-12-31 | ₩12.83 Billion | +9.53% |
| 2014-12-31 | ₩11.71 Billion | -50.08% |
| 2012-12-31 | ₩23.46 Billion | -14.00% |
| 2011-12-31 | ₩27.28 Billion | +1.94% |
| 2010-12-31 | ₩26.76 Billion | -14.17% |
| 2009-12-31 | ₩31.18 Billion | -- |